Methylprednisolone vs Rituximab

## Methylprednisolone vs Rituximab: Overview

This comparison examines the pharmacological differences between **Methylprednisolone** and **Rituximab**.

## Mechanism of Action

**Methylprednisolone**: Intermediate-acting synthetic glucocorticoid.

**Rituximab**: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.

## Pharmacokinetics

**Half-life**: Methylprednisolone — 18-36 hours; Rituximab — 22 days.

## Chemical Properties

**Molecular Formula**: Methylprednisolone — C22H30O5; Rituximab — N/A.

**Molecular Weight**: Methylprednisolone — 374.4710 g/mol; Rituximab — N/A.

**Type**: Methylprednisolone — Small molecule; Rituximab — Antibody.